Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
3 studies found for:    9562579 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Clinical and Basic Investigations Into Hermansky-Pudlak Syndrome
Conditions: Albinism;   Intestinal Disease;   Kidney Disease;   Myocardial Disease;   Pulmonary Fibrosis
Intervention:
2 Active, not recruiting
Has Results
Oral Pirfenidone for the Pulmonary Fibrosis of Hermansky-Pudlak Syndrome
Conditions: Albinism;   Inborn Errors of Metabolism;   Oculocutaneous Albinism;   Platelet Storage Pool Deficiency;   Pulmonary Fibrosis
Interventions: Drug: Pirfenidone;   Drug: Placebo
3 Recruiting Procurement and Analysis of Specimens From Individuals With Pulmonary Fibrosis
Condition: Pulmonary Fibrosis
Intervention:

Indicates status has not been verified in more than two years